Assessment of Outcomes after Stopping Tyrosine Kinase Inhibitors among Patients with Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial

Ehab Atallah, Charles A. Schiffer, Jerald P. Radich, Kevin P. Weinfurt, Mei Jie Zhang, Javier Pinilla-Ibarz, Vamsi Kota, Richard A. Larson, Joseph O. Moore, Michael J. Mauro, Michael W.N. Deininger, James E. Thompson, Vivian G. Oehler, Martha Wadleigh, Neil P. Shah, Ellen K. Ritchie, Richard T. Silver, Jorge Cortes, Li Lin, Alexis VisotckyArielle Baim, Jill Harrell, Bret Helton, Mary Horowitz, Kathryn E. Flynn

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Assessment of Outcomes after Stopping Tyrosine Kinase Inhibitors among Patients with Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences